Search for: "Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC" Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC (Fed. Cir. 2020)
11 May 2020, 9:59 pm by Patent Docs
Amneal Pharmaceuticals LLC") is most frequently rebutted by the doctrine of prosecution history estoppel ("Pharma Tech Solutions, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Supreme Court Denies Another Certiorari Petition on Doctrine of Equivalents
16 Jun 2020, 9:59 pm by Patent Docs
Slayback Pharma LLC and Indivior Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Disclosure-Dedication Rule: An Effective Tool Against Infringement Claims Under the Doctrine of Equivalents
13 Jul 2020, 1:15 pm by Sanjeev Mahanta, Ph.D., J.D.
Slayback Pharma LLC, No. 2019-1924 (Fed. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
CAFC reviews "disclosed, not claimed, dedicated" in Eagle Pharmaceuticals; D. Delaware affirmed
8 May 2020, 6:57 pm by Lawrence B. Ebert
Eagle suedSlayback Pharma LLC for infringing four patents coveringEagle’s brand name bendamustine pharmaceutical product. [read post]
IPBiz - http://ipbiz.blogspot.com/